| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/03/2008 | US20080081058 Composition for Promoting Vascular Smooth Muscle Relaxation |
| 04/03/2008 | US20080081056 Depolymerized polysaccharide-based hydrogel adhesive and methods of use thereof |
| 04/03/2008 | US20080081053 treating acute myelogenous leukemia (AML) by administering an mTOR inhibitor (mammalian target of rapamycin); rapamycin, temsirolimus (CC1779), everolimus |
| 04/03/2008 | US20080081052 Topical compositions containing solubilized allantoin and related methods |
| 04/03/2008 | US20080081051 Method of manufacturing anti-tumor and anti-viral compositions |
| 04/03/2008 | CA2664944A1 Use of glycerophospholipids for joint lubrication |
| 04/03/2008 | CA2664773A1 Solubilized non-steroidal anti-inflammatory drugs |
| 04/03/2008 | CA2664669A1 A method of administering a film product containing a drug |
| 04/03/2008 | CA2664583A1 Probiotic oral dosage forms |
| 04/03/2008 | CA2664455A1 Pharmaceutical compositions of aripiprazole |
| 04/03/2008 | CA2664420A1 Effervescent ibuprofen formulation with high dissolution rate and process for its preparation |
| 04/03/2008 | CA2664290A1 Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
| 04/03/2008 | CA2663941A1 Stabilized solid forms and method for the production thereof |
| 04/03/2008 | CA2663871A1 Multi-core solid dosage form comprising a transparent coating between said cores |
| 04/03/2008 | CA2663558A1 Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof |
| 04/03/2008 | CA2662571A1 Pharmaceutical compositions |
| 04/03/2008 | CA2662383A1 Organic compounds |
| 04/03/2008 | CA2661576A1 Stabilizing compositions for antibiotics and methods of use |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1905477A1 Beneficial agent delivery system |
| 04/02/2008 | EP1905456A1 Drug-containing photocrosslinked hyaluronic acid derivative gel |
| 04/02/2008 | EP1905455A1 Capsule coating composition |
| 04/02/2008 | EP1905453A1 Preservative composition for ophthalmic use |
| 04/02/2008 | EP1905446A1 Use of PYY analogs and antagonists of PPY receptors for manipulating satiety |
| 04/02/2008 | EP1905444A1 Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 04/02/2008 | EP1905435A2 Titration dosing regimen for controlled release tramadol |
| 04/02/2008 | EP1905433A1 Percutaneous absorption patch with application position indicating function, and iontophoresis device |
| 04/02/2008 | EP1905432A1 Nanoparticulate and controlled release compositions comprising a cephalosporin |
| 04/02/2008 | EP1905431A1 Pravastatin pharmaceutical formulations and methods of their use |
| 04/02/2008 | EP1905430A1 Tablet |
| 04/02/2008 | EP1905429A1 Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles |
| 04/02/2008 | EP1905428A1 Ibuprofen efferscent tablet with dissolution rate and process for preparation |
| 04/02/2008 | EP1905427A1 Rapidly solubilising formulation of non-steroidal anti-inflammatory drugs |
| 04/02/2008 | EP1905426A2 Anti-acid pharmaceutical composition in powder form; pharmaceutical preparation containing it and process for making it |
| 04/02/2008 | EP1905425A1 Reverse vesicle containing a hydrophobic phase |
| 04/02/2008 | EP1905424A2 Pharmaceutical composition comprising stabilized statin particles |
| 04/02/2008 | EP1905309A1 Uses of oil bodies |
| 04/02/2008 | EP1904932A2 Nanoparticle fabrication methods, systems, and materials |
| 04/02/2008 | EP1904844A2 Compositions and methods for enhancing axon regeneration |
| 04/02/2008 | EP1904553A1 Method of biomolecule immobilization on polymers using click-type chemistry |
| 04/02/2008 | EP1904297A2 Compositions comprising elemental metals and uses therefor |
| 04/02/2008 | EP1904219A1 Method of particle formation |
| 04/02/2008 | EP1904180A2 Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist |
| 04/02/2008 | EP1904158A2 Collapsible patch with microneedle array |
| 04/02/2008 | EP1904148A2 Device for the controlled release of a predefined quantity of a substance |
| 04/02/2008 | EP1904147A2 Medicament delivery article, accessory&system |
| 04/02/2008 | EP1904146A1 Device for the controlled release of a predefined quantity of a substance |
| 04/02/2008 | EP1904099A2 Thermoreversible immuno- adjuvant emulsion |
| 04/02/2008 | EP1904090A2 Bone morphogenetic protein formulations |
| 04/02/2008 | EP1904071A2 Compositions of antiviral compound |
| 04/02/2008 | EP1904067A2 Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition |
| 04/02/2008 | EP1904052A1 Liquid pharmaceutical formulations of docetaxel |
| 04/02/2008 | EP1904051A1 Bicalutamide adsorbates, process for preparing same, and pharmaceutical compositions thereof |
| 04/02/2008 | EP1904042A2 Solubilsation products of an active ingredient extract |
| 04/02/2008 | EP1904041A2 Nanoparticulate clarithromycin formulations |
| 04/02/2008 | EP1904040A2 Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate |
| 04/02/2008 | EP1904039A2 Controlled release dosage formulation of duloxetine |
| 04/02/2008 | EP1904038A2 Compressed pharmaceutical composition comprising coated pellets and a direct compression mixture, and method of preparation thereof |
| 04/02/2008 | EP1904037A1 Prolonged release formulation of active principles having a ph-dependent solubility |
| 04/02/2008 | EP1904036A2 Bioelectro-osmotic engine fluid delivery device |
| 04/02/2008 | EP1904034A2 Gastroretentive formulations and manufacturing process thereof |
| 04/02/2008 | EP1904033A2 Method for producing pharmaceutical compositions containing glimepiride |
| 04/02/2008 | EP1904032A1 Fentanyl formulation containing an essential oil |
| 04/02/2008 | EP1904031A2 A substantially water-free pressurised propellant mixture |
| 04/02/2008 | EP1904030A2 Semi-permeable compositions providing reduced drying time for osmotic dosage forms |
| 04/02/2008 | EP1904029A2 Oral, quickly disintegrating film, which cannot be spit out, for a neuroleptic drug |
| 04/02/2008 | EP1904028A1 Estrogen compositions for vaginal administration |
| 04/02/2008 | EP1903866A1 Improved delivery of tetrahydrocannabinol |
| 04/02/2008 | EP1558226A4 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 04/02/2008 | EP1539155B1 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 04/02/2008 | EP1476019B1 Aqueous antiseptic based on bispyridiniumalkanes |
| 04/02/2008 | EP1432449B1 Water-in-oil emulsions comprising oil soluble vinyl polymers carrying acidic groups in side chains, compositions, and methods |
| 04/02/2008 | EP1424898A4 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 04/02/2008 | EP1424889A4 Method for treating lung cancers |
| 04/02/2008 | EP1265610A4 Method for reducing or eliminating smoking |
| 04/02/2008 | EP1204761B1 Targeted artificial gene delivery |
| 04/02/2008 | EP1091729B1 Spray-dried microparticles of insulin for inhalation |
| 04/02/2008 | CN101155597A Nucleic acid constructs |
| 04/02/2008 | CN101155595A Antitumor agent and dnase |
| 04/02/2008 | CN101155594A Cream loaded with shellfish firing product powder and process for producing the same |
| 04/02/2008 | CN101155586A Oral dosage form comprising rosiglitazone |
| 04/02/2008 | CN101155585A Oral dosage form comprising rosiglitazone |
| 04/02/2008 | CN101155580A Propofol-containing fat emulsion |
| 04/02/2008 | CN101155578A Method for a treatment with a medicament combination and medicament combinations suitable for the same |
| 04/02/2008 | CN101155577A Local treatment of neurofibromas |
| 04/02/2008 | CN101153053A Bone-peptide, producing method, pharmaceutical composition and uses thereof |
| 04/02/2008 | CN101152568A Polypeptide combination preparations having functions of accelerating angiogenesis, organ reactivation and wound healing |
| 04/02/2008 | CN101152564A Method for preparing compound biotin chitosan film and application of the same in reactivation of periodontium |
| 04/02/2008 | CN101152559A Pharmaceutical composition having function of protecting and treating nerve damnification |
| 04/02/2008 | CN101152551A Traditional Chinese medicine for treating early external carbuncle |
| 04/02/2008 | CN101152545A Turmeric water-solubility saponin liposome, preparing method and uses the same |
| 04/02/2008 | CN101152544A Ruheneixiao granules and method for preparing the same |
| 04/02/2008 | CN101152543A Medicament for treating gastralgia |
| 04/02/2008 | CN101152533A Traditional Chinese medicine composition for treating skin diseases |
| 04/02/2008 | CN101152532A Traditional Chinese medicine preparations for treating gynecology disease |
| 04/02/2008 | CN101152530A Method for preparing defervesce and promoting digestion capsule for children |
| 04/02/2008 | CN101152529A Externally used compound traditional Chinese medicine painting preparation for treating alopecia and method for preparing the same |
| 04/02/2008 | CN101152517A Biological agent for releasing and smoothing emotional stress, and method for preparing the same |
| 04/02/2008 | CN101152516A Compound traditional Chinese medicine preparation about silk moth and method for preparing the same |
| 04/02/2008 | CN101152511A Medicament for treating hyperthyroidism disease and method of preparing the same |